Key result
Heterotopic bicaval implantation improves heart failure and induces reverse RV remodeling in a high-risk patient.
Why the study?
Does heterotopic bicaval implantation of a transcatheter valve system improve heart failure control and right ventricular remodeling in a high-risk patient with severe tricuspid regurgitation?
Does heterotopic bicaval implantation of a transcatheter valve system improve heart failure control and right ventricular remodeling in a high-risk patient with severe tricuspid regurgitation?
Heterotopic bicaval implantation of a transcatheter valve system may be an effective option for severe tricuspid regurgitation in patients with prohibitive surgical risk and unsuitable anatomy for edge-to-edge repair.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for heterotopic bicaval implantation in prohibitive-risk severe TR; leaves open prospective validation of HF control and RV remodeling.
The authors describe the first case of heterotopic bicaval implantation of transcatheter valve system in Russia for correction of severe tricuspid regurgitation in a patient with extremely high surgical risk and contraindication for redo surgery under cardiopulmonary bypass. The patient did not meet anatomical criteria for transcatheter edge-to-edge tricuspid valve repair. This case demonstrates the effectiveness of heterotopic bicaval implantation for tricuspid valve disease in high-risk patient with better control of chronic heart failure and positive reverse right ventricular remodeling over a 12-month follow-up.
No takes yet. Share an insight, caveat, or question.
Imaev et al. (2025) studied this question. Heterotopic bicaval implantation effectively improved chronic heart failure and induced positive reverse right ventricular remodeling in a high-risk patient over 12 months.
Synapse has enriched 10 related papers. Consider them for comparative context: